Journal
PHARMACEUTICALS
Volume 16, Issue 5, Pages -Publisher
MDPI
DOI: 10.3390/ph16050686
Keywords
coenzyme Q10; antioxidant; molecular hydrogen; short-chain fatty acids; trimethylamine; gut microbiota
Categories
Ask authors/readers for more resources
The main route of drug administration for Coenzyme Q10 (CoQ10) is oral administration, which has a bioavailability of about 2-3%. Prolonged use of CoQ10 can lead to higher concentrations in the intestine and impact the gut microbiota and biomarkers it produces. In a study on Wistar rats, oral administration of CoQ10 at a dose of 30 mg/kg/day for 21 days resulted in increased hydrogen concentration, total SCFA concentration, and relative abundance of certain bacterial groups, as well as decreased TMA levels and relative representation of Helicobacter. The antioxidant effect of orally administered CoQ10 may involve modification of the gut microbiota composition, increased hydrogen generation, and protection of the gut barrier function.
The predominant route of administration of drugs with coenzyme Q10 (CoQ10) is administration per os. The bioavailability of CoQ10 is about 2-3%. Prolonged use of CoQ10 to achieve pharmacological effects contributes to the creation of elevated concentrations of CoQ10 in the intestinal lumen. CoQ10 can have an effect on the gut microbiota and the levels of biomarkers it produces. CoQ10 at a dose of 30 mg/kg/day was administered per os to Wistar rats for 21 days. The levels of gut microbiota biomarkers (hydrogen, methane, short-chain fatty acids (SCFA), and trimethylamine (TMA)) and taxonomic composition were measured twice: before the administration of CoQ10 and at the end of the experiment. Hydrogen and methane levels were measured using the fasting lactulose breath test, fecal and blood SCFA and fecal TMA concentrations were determined by NMR, and 16S sequencing was used to analyze the taxonomic composition. Administration of CoQ10 for 21 days resulted in a 1.83-fold (p = 0.02) increase in hydrogen concentration in the total air sample (exhaled air + flatus), a 63% (p = 0.02) increase in the total concentration of SCFA (acetate, propionate, butyrate) in feces, a 126% increase in butyrate (p = 0.04), a 6.56-fold (p = 0.03) decrease in TMA levels, a 2.4-fold increase in relative abundance of Ruminococcus and Lachnospiraceae AC 2044 group by 7.5 times and a 2.8-fold decrease in relative representation of Helicobacter. The mechanism of antioxidant effect of orally administered CoQ10 can include modification of the taxonomic composition of the gut microbiota and increased generation of molecular hydrogen, which is antioxidant by itself. The evoked increase in the level of butyric acid can be followed by protection of the gut barrier function.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available